Form 4: Guardant Health Executive Sells Shares

Guardant Health Chief People Officer Terilyn J. Monroe reported a sale of 3,832 shares of common stock on April 6, 2026, for $92.68 per share.

Summary

• Terilyn J. Monroe, Chief People Officer at Guardant Health, Inc., sold 3,832 shares of common stock on April 6, 2026.
• The transaction was executed at a price of $92.68 per share.
• Following the transaction, Ms. Monroe beneficially owns 20,990 shares of common stock directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the insider sale of shares, which can sometimes be interpreted as a bearish signal by the market, despite potential personal financial reasons for the transaction.

Negatives

• Executive sale of a significant number of shares could be perceived negatively by the market.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, which report insider transactions, are closely watched by investors. Executive stock sales can sometimes signal a lack of confidence in future stock performance, although they can also be for personal financial planning reasons.

Stakeholder Impact

• Shareholders may view the executive's sale of shares with caution, potentially impacting short-term stock sentiment.

Key Dates

Recommendation

The filing reports an insider sale, which is a neutral to slightly negative event. Without further context on the reasons for the sale or broader company performance, a 'hold' recommendation is prudent, suggesting investors monitor further developments.

Keywords

Guardant Health, SEC Form 4, Insider Trading, Stock Sale, Terilyn J. Monroe, Common Stock, Beneficial Ownership